Author: ViraPulse

In a potential medical game-changer, scientists have developed experimental eye drops that may dissolve cataracts—potentially eliminating the need for invasive surgery, which is currently the only available treatment for this leading cause of blindness. This innovation targets the root cause of cataracts: misfolded proteins that clump together and cloud the eye’s natural lens. If successful Read more

For decades, the idea that depression is caused by a “chemical imbalance”—specifically, low serotonin—has shaped how doctors, patients, and the public understand mental illness. It’s the explanation printed in pharmaceutical ads, echoed in clinics, and accepted by up to 90% of the public. But a sweeping umbrella review by researchers at University College London (UCL) Read more

Here’s a bit of hope for anyone dismayed by the growing patch of silver in the mirror: scientists may have uncovered a way to reverse gray hair—and it doesn’t involve dye. A groundbreaking study from researchers at NYU Grossman School of Medicine suggests that hair graying may not be as permanent as we once thought. Read more

Scientists Identify “Aging Messenger” in the Blood—and How Blocking It Reversed Decline in Mice Imagine if aging wasn’t just about time but also a signal traveling through your bloodstream—infecting cells with sentience-stealing whispers. A new study suggests this might be closer to reality than we thought. A protein called HMGB1—specifically an oxidized form dubbed ReHMGB1—is Read more

A coalition of ALS patients, caregivers, and advocates has submitted a citizens’ petition to the FDA, requesting approval of NurOwn (debamestrocel)—a stem-cell therapy developed for amyotrophic lateral sclerosis (ALS). Their push comes amid growing frustration over burocratic delays and mounting real-world data indicating potential patient benefits. 🚨 What Is NurOwn—and Why Does It Matter? NurOwn Read more